Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
92.63
-0.07 (-0.08%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Amedisys Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Amedisys stock have an average target of 100.8, with a low estimate of 100 and a high estimate of 101. The average target predicts an increase of 8.82% from the current stock price of 92.63.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amedisys stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +9.04% | Mar 4, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +9.04% | Feb 12, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +9.04% | Jul 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +9.04% | Jul 25, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2024 |
Financial Forecast
Revenue This Year
2.52B
from 2.35B
Increased by 7.31%
Revenue Next Year
2.66B
from 2.52B
Increased by 5.63%
EPS This Year
4.99
from 1.31
Increased by 280.75%
EPS Next Year
5.26
from 4.99
Increased by 5.47%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.6B | 2.8B | 2.9B |
| Avg | 2.5B | 2.7B | 2.8B |
| Low | 2.4B | 2.5B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.4% | 11.1% | 9.1% |
| Avg | 7.3% | 5.6% | 6.0% |
| Low | 1.9% | -1.2% | 1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.46 | 5.63 | 5.51 |
| Avg | 4.99 | 5.26 | 5.36 |
| Low | 4.49 | 4.80 | 5.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 316.8% | 12.8% | 4.8% |
| Avg | 280.7% | 5.5% | 1.8% |
| Low | 242.6% | -3.7% | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.